Needham & Company LLC Begins Coverage on Amprius Technologies (NYSE:AMPX)

Research analysts at Needham & Company LLC began coverage on shares of Amprius Technologies (NYSE:AMPX) in a note issued to investors on Thursday, MarketBeat.com reports. The firm set a “buy” rating and a $20.00 price target on the stock. Needham & Company LLC’s price objective would indicate a potential upside of 61.03% from the stock’s current price.

Other equities analysts also recently issued research reports about the stock. Weiss Ratings reissued a “sell (e+)” rating on shares of Amprius Technologies in a report on Wednesday, January 21st. Roth Mkm set a $14.00 price objective on shares of Amprius Technologies and gave the company a “buy” rating in a research report on Wednesday, October 22nd. Oppenheimer reissued an “outperform” rating and set a $17.00 target price on shares of Amprius Technologies in a research note on Tuesday, December 23rd. Cantor Fitzgerald raised their price target on shares of Amprius Technologies from $12.00 to $16.00 and gave the company an “overweight” rating in a research note on Friday, November 7th. Finally, Northland Securities set a $20.00 price target on Amprius Technologies in a report on Tuesday, October 7th. Seven investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $16.57.

Amprius Technologies Trading Down 8.5%

NYSE:AMPX opened at $12.42 on Thursday. The stock has a 50 day moving average of $10.27 and a 200-day moving average of $10.02. The firm has a market capitalization of $1.62 billion, a PE ratio of -47.77 and a beta of 3.04. Amprius Technologies has a 52 week low of $1.70 and a 52 week high of $16.03.

Amprius Technologies (NYSE:AMPX) last announced its quarterly earnings results on Thursday, November 6th. The company reported ($0.03) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.06) by $0.03. The business had revenue of $21.43 million for the quarter, compared to the consensus estimate of $16.45 million. Amprius Technologies had a negative return on equity of 38.85% and a negative net margin of 53.16%. As a group, analysts predict that Amprius Technologies will post -0.45 EPS for the current fiscal year.

Insider Buying and Selling

In other Amprius Technologies news, Director Kang Sun sold 43,185 shares of the company’s stock in a transaction that occurred on Tuesday, January 20th. The stock was sold at an average price of $11.03, for a total value of $476,330.55. Following the completion of the sale, the director directly owned 1,403,651 shares in the company, valued at $15,482,270.53. This represents a 2.98% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CTO Constantin Ionel Stefan sold 39,690 shares of the stock in a transaction on Wednesday, January 28th. The shares were sold at an average price of $12.00, for a total value of $476,280.00. Following the transaction, the chief technology officer directly owned 748,696 shares of the company’s stock, valued at approximately $8,984,352. The trade was a 5.03% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 3,399,331 shares of company stock valued at $37,048,615. Company insiders own 12.90% of the company’s stock.

Institutional Trading of Amprius Technologies

Several institutional investors have recently modified their holdings of AMPX. Vanguard Group Inc. boosted its stake in Amprius Technologies by 9.5% during the fourth quarter. Vanguard Group Inc. now owns 7,128,657 shares of the company’s stock valued at $56,245,000 after buying an additional 616,037 shares in the last quarter. Invesco Ltd. lifted its holdings in Amprius Technologies by 113.3% in the 3rd quarter. Invesco Ltd. now owns 2,379,384 shares of the company’s stock valued at $25,031,000 after acquiring an additional 1,263,846 shares during the last quarter. UBS Group AG boosted its position in shares of Amprius Technologies by 35.5% during the 4th quarter. UBS Group AG now owns 2,098,946 shares of the company’s stock valued at $16,561,000 after purchasing an additional 549,892 shares in the last quarter. BNP Paribas Financial Markets boosted its position in shares of Amprius Technologies by 1,117.9% during the 3rd quarter. BNP Paribas Financial Markets now owns 1,943,905 shares of the company’s stock valued at $20,450,000 after purchasing an additional 1,784,291 shares in the last quarter. Finally, Voloridge Investment Management LLC acquired a new position in shares of Amprius Technologies in the 3rd quarter worth approximately $19,737,000. Institutional investors and hedge funds own 5.04% of the company’s stock.

Key Amprius Technologies News

Here are the key news stories impacting Amprius Technologies this week:

• Positive Sentiment: Needham initiated coverage with a Buy and a $20 price target (roughly +61% upside from current levels), a bullish analyst catalyst that likely drew buyer interest and helped fuel recent gains. Needham initiates coverage of Amprius
• Positive Sentiment: MarketBeat highlighted Amprius’ expanding production capacity and new South Korean manufacturing partners, noting the company is ahead of plan and positioning for an improved path to profitability ahead of FY2025 Q4 results (late March) — a concrete operational improvement that supports longer‑term upside. 5 Stocks to Buy in February: Last Year’s Winners Aren’t Done Yet (AMPX)
• Positive Sentiment: Unusual options activity: a large purchase of call options (22,391 contracts) suggests elevated bullish/speculative interest and short‑term upside betting by traders — this can amplify intraday moves and volatility.
• Neutral Sentiment: Several outlets ran takeaways asking whether recent multi‑month gains make AMPX “too late” to buy and examining valuation after a big run; these pieces increase retail attention but don’t settle fundamentals one way or the other. Is It Too Late To Consider Buying Amprius Technologies (AMPX)
• Negative Sentiment: Zacks noted a recent sharp intraday gain but flagged that the trend in earnings‑estimate revisions does not support sustained upside — a warning that analysts’ expectations may not be accelerating enough to justify the rally. Amprius (AMPX) Moves 13.4% Higher: Will This Strength Last?
• Negative Sentiment: Fundamental risk: Amprius still shows negative net margin and negative ROE and trades with a high beta — meaning the stock is sensitive to sentiment swings and could face profit‑taking or re‑rating if upcoming earnings fail to show clear progress toward profitability.

Amprius Technologies Company Profile

Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.